Clinical Trial: Efficacy and Safety of Low-Intensity Single-Wavelength Red Light Therapy for Controlling Myopia with Intermittent Exotropia (China)

China, Oct. 28 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Low-Intensity Single-Wavelength Red Light Therapy for Controlling Myopia with Intermittent Exotropia'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135241

Registration Time: 2026/10/27

Type: Interventional study

Primary Sponsor: Shanghai Eye Disease Prevention and Treatment Center

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=322822

Published by HT Digital Content Services with permission from Health Daily Digest....